NCT02784171 2024-12-10Pembrolizumab in Patients With Advanced Malignant Pleural MesotheliomaCanadian Cancer Trials GroupPhase 2/3 Completed520 enrolled 16 charts 3 FDA
NCT00651456 2023-03-13MAPSIntergroupe Francophone de Cancerologie ThoraciquePhase 2/3 Completed448 enrolled
NCT01769066 2016-02-23Clinical Value of Sequential Gefitinib With Pemetrexed/Platinum for Advanced NSCLCFudan UniversityPhase 2/3 Completed117 enrolled